Quest Diagnostics Incorporated (DGX) vs Medline Inc. (MDLN)

A side-by-side comparison of Quest Diagnostics Incorporated and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DGX vs MDLN

growth of $100 · dividends reinvested · last 1y
DGX +32.9% (+32.9%/yr)MDLN -20.7% (-20.7%/yr)DGX compounded faster over this window
80100120140Start $1002026$133$79
DGX MDLN

DGX vs MDLN: by the numbers

  • •MDLN is the larger company ($29.34B vs $26.08B market cap).
  • •DGX trades at the lower trailing earnings multiple (25.09 vs 40.34 P/E), one valuation lens rather than an overall verdict.
  • •DGX converts more revenue to profit (9.19% vs 2.31% net margin).
  • •DGX pays a dividend (1.41% yield), while MDLN has no payments in the available dividend history.

Metrics side by side

Valuation

MetricDGXMDLN
P/E ratio25.0940.34
Forward P/E21.1223.24
P/S ratio2.260.98
P/B ratio3.472.54
EV / EBITDA15.9414.39
FCF yield4.68%4.57%

Profitability

MetricDGXMDLN
Gross margin33.15%25.02%
Operating margin14.14%6.07%
Net margin9.19%2.31%
ROE14.13%5.97%
ROIC8.25%4.05%

Dividends

MetricDGXMDLN
Dividend yield1.41%N/A
Payout ratio35.24%N/A

Growth (annualized)

MetricDGXMDLN
Revenue CAGR (5Y)0.89%N/A
EPS CAGR (5Y)-3.65%N/A
FCF CAGR (5Y)-10.89%N/A
Total return CAGR (5Y)10.93%N/A

Frequently asked

Which has the lower trailing P/E, DGX or MDLN?
DGX has the lower trailing P/E: DGX trades at 25.09 and MDLN at 40.34. P/E is one valuation measure and does not by itself establish which business is cheaper.
Does DGX or MDLN pay a bigger dividend?
DGX pays a dividend (1.41% yield), while MDLN has no payments in the available dividend history.
Is DGX or MDLN more profitable?
DGX runs the higher net margin — DGX at 9.19% versus MDLN at 2.31%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.